{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:41:32Z","timestamp":1792219292578,"version":"4.4.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018916","name":"SuZhou Municipal Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018916","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.mtbio.2026.103705","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:22:27Z","timestamp":1790148147000},"page":"103705","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Oxygen-augmented erythrocyte-liposome hybrids to overcome paclitaxel resistance in triple-negative breast cancer metastasis via enhanced ferroptosis"],"prefix":"10.1016","volume":"41","author":[{"given":"Xunyi","family":"You","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kehui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee Shan","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8693-1070","authenticated-orcid":false,"given":"Subbu S.","family":"Venkatraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9328-8159","authenticated-orcid":false,"given":"Ye","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.mtbio.2026.103705_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16081483","article-title":"Targeting pivotal hallmarks of cancer for enhanced therapeutic strategies in triple-negative breast cancer Treatment-In vitro, in vivo and clinical trials literature review","volume":"16","author":"Szulc","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.mtbio.2026.103705_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0293833","article-title":"Survival according to the site of metastasis in triple-negative breast cancer patients: the Peruvian experience","volume":"19","author":"Piedra-Delgado","year":"2024","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103705_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s11671-024-03985-y","article-title":"Targeting triple negative breast cancer stem cells using nanocarriers","volume":"19","author":"Dasari","year":"2024","journal-title":"Discov Nano"},{"issue":"2","key":"10.1016\/j.mtbio.2026.103705_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgeb.2025.100496","article-title":"Co-expression of HIF1A with multi-drug transporters (P-GP, MRP1, and BCRP) in chemoresistant breast, colorectal, and ovarian cancer cells","volume":"23","author":"Nath","year":"2025","journal-title":"J. Genet. Eng. Biotechnol."},{"key":"10.1016\/j.mtbio.2026.103705_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1710230","article-title":"Inhibition of CRM1 reverses hypoxia-driven chemoresistance in acute myeloid leukemia via overcoming HIF-1\u03b1-mediated lysosomal sequestration","volume":"16","author":"Feng","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mtbio.2026.103705_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1199105","article-title":"Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens","volume":"13","author":"Srivastava","year":"2023","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103705_bib7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41698-025-01178-z","article-title":"Minibeam radiation therapy remodels tumor microenvironment and suppresses HIF-1\u03b1\/VEGFR axis to overcome radioresistance in triple-negative breast cancer","volume":"9","author":"Fang","year":"2025","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.mtbio.2026.103705_bib8","article-title":"Hypoxia-driven angiogenesis and metabolic reprogramming in vascular tumors","volume":"13","author":"Liu","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.mtbio.2026.103705_bib9","article-title":"Endothelial cell in tumor angiogenesis: origins, mechanisms, and therapeutic implication","volume":"12","author":"Han","year":"2025","journal-title":"Genes Dis."},{"issue":"4","key":"10.1016\/j.mtbio.2026.103705_bib10","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/bjc.1955.55","article-title":"The histological structure of some human lung cancers and the possible implications for radiotherapy","volume":"9","author":"Thomlinson","year":"1955","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103705_bib11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1186\/s12951-024-02717-9","article-title":"Hemoglobin nanoclusters-mediated regulation of KPNA4 in hypoxic tumor microenvironment enhances photodynamic therapy in hepatocellular carcinoma","volume":"22","author":"Wang","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103705_bib12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1525-1594.2011.01418.x","article-title":"Liposome-encapsulated hemoglobin ameliorates tumor hypoxia and enhances radiation therapy to suppress tumor growth in mice","volume":"36","author":"Murayama","year":"2012","journal-title":"Artif. Organs"},{"issue":"12 Pt 1","key":"10.1016\/j.mtbio.2026.103705_bib13","first-page":"6387","article-title":"A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs","volume":"46","author":"Matsumura","year":"1986","journal-title":"Cancer Res."},{"key":"10.1016\/j.mtbio.2026.103705_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2025.214636","article-title":"Enhanced permeability and retention (EPR) effect: advances in nanomedicine for improved tumor targeting","volume":"181","author":"Khan","year":"2026","journal-title":"Biomater. Adv."},{"issue":"12","key":"10.1016\/j.mtbio.2026.103705_bib15","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/s41563-020-0755-z","article-title":"The dose threshold for nanoparticle tumour delivery","volume":"19","author":"Ouyang","year":"2020","journal-title":"Nat. Mater."},{"key":"10.1016\/j.mtbio.2026.103705_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/rb\/rbad045","article-title":"Hybrid liposome-erythrocyte drug delivery system for tumor therapy with enhanced targeting and blood circulation","volume":"10","author":"Zhu","year":"2023","journal-title":"Regen. Biomater."},{"issue":"46","key":"10.1016\/j.mtbio.2026.103705_bib17","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.1002\/smll.201502388","article-title":"Red blood cell membrane as a biomimetic nanocoating for prolonged circulation time and reduced accelerated blood clearance","volume":"11","author":"Rao","year":"2015","journal-title":"Small"},{"issue":"3","key":"10.1016\/j.mtbio.2026.103705_bib18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cpt.2025.07.003","article-title":"Investigating hypoxia-inducible factor signaling in cancer: mechanisms, clinical implications, targeted therapeutic strategies, and resistance","volume":"4","author":"Shaikat","year":"2026","journal-title":"Cancer Pathog. Ther."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103705_bib19","doi-asserted-by":"crossref","first-page":"362","DOI":"10.2174\/0122117385328105241216042016","article-title":"An enhanced scrutiny of mechanistic and translational approaches to extinguish cancer hypoxia","volume":"14","author":"Radhakrishnan","year":"2024","journal-title":"Pharm. Nanotechnol."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103705_bib20","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1021\/acs.biomac.1c01403","article-title":"Polymer micelles vs polymer-lipid hybrid vesicles: a comparison using RAW 264.7 cells","volume":"23","author":"Ade","year":"2022","journal-title":"Biomacromolecules"},{"issue":"19","key":"10.1016\/j.mtbio.2026.103705_bib21","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.1158\/1078-0432.CCR-11-0397","article-title":"Metabolic imaging: a link between lactate dehydrogenase A, lactate, and tumor phenotype","volume":"17","author":"Serganova","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.mtbio.2026.103705_bib22","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.neo.2015.08.005","article-title":"Metabolic plasticity of metastatic breast cancer cells: adaptation to changes in the microenvironment","volume":"17","author":"Sim\u00f5ES","year":"2015","journal-title":"Neoplasia"},{"issue":"6","key":"10.1016\/j.mtbio.2026.103705_bib23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrc2397","article-title":"Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response","volume":"8","author":"Dewhirst","year":"2008","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103705_bib24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12951-022-01349-1","article-title":"Enhanced tumor accumulation and therapeutic efficacy of liposomal drugs through over-threshold dosing","volume":"20","author":"Ao","year":"2022","journal-title":"J. Nanobiotechnol."}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426009506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426009506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:01:07Z","timestamp":1792216867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006426009506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":24,"alternative-id":["S2590006426009506"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103705","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxygen-augmented erythrocyte-liposome hybrids to overcome paclitaxel resistance in triple-negative breast cancer metastasis via enhanced ferroptosis","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103705","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103705"}}